Keros Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KROS and other ETFs, options, and stocks.About KROS
Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need.
CEOJasbir S. Seehra
CEOJasbir S. Seehra
Employees169
Employees169
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2015
Founded2015
Employees169
Employees169
KROS Key Statistics
Market cap570.78M
Market cap570.78M
Price-Earnings ratio12.22
Price-Earnings ratio12.22
Dividend yield—
Dividend yield—
Average volume430.46K
Average volume430.46K
High today$18.74
High today$18.74
Low today$18.37
Low today$18.37
Open price$18.65
Open price$18.65
Volume32.17K
Volume32.17K
52 Week high$22.55
52 Week high$22.55
52 Week low$9.12
52 Week low$9.12
Stock Snapshot
Keros Therapeutics(KROS) stock is priced at $18.74, giving the company a market capitalization of 570.78M. It carries a P/E multiple of 12.22.
On 2026-01-20, Keros Therapeutics(KROS) stock traded between a low of $18.37 and a high of $18.74. Shares are currently priced at $18.74, which is +2.0% above the low and 0.0% below the high.
Keros Therapeutics(KROS) shares are trading with a volume of 32.17K, against a daily average of 430.46K.
In the last year, Keros Therapeutics(KROS) shares hit a 52-week high of $22.55 and a 52-week low of $9.12.
In the last year, Keros Therapeutics(KROS) shares hit a 52-week high of $22.55 and a 52-week low of $9.12.
Analyst ratings
56%
of 9 ratingsBuy
55.6%
Hold
44.4%
Sell
0%
People also own
Based on the portfolios of people who own KROS. This list is generated using Robinhood data, and it’s not a recommendation.